Highlights
NASDAQ: ZLAB       Zai Lab Ltd
Last Price Today's Change   Day's Range   Trading Volume
84.50   -3.99 (4.51%)  83.29 - 87.42  355,114

Overview

 
Avg Volume (4 weeks):289,290
4 Weeks Range:81.70 - 95.515
4 Weeks Price Volatility (%):
20.27%
52 Weeks Range:32.651 - 95.515
52 Weeks Price Volatility (%):
82.48%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. The company operates through the single segment being Developing and commercializing proprietary therapeutics.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1579  4444  223  3154 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MGEN 1.26+0.74 
 TTNP 0.167+0.038 
 GE 7.42+0.32 
 LK 1.38+1.38 
 AAPL 111.20-5.40 
 SQQQ 24.65+2.59 
 NIO 27.51-0.93 
 NAKD 0.083-0.009 
 SNAP 42.86+1.32 
 BAC 23.47-0.38